Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: J Toxicol Environ Health A. 2009;72(1):30–38. doi: 10.1080/15287390802445483

Table 3.

Human studies of the PM-ventricular arrhythmia association

Authors Year n Setting Female Outcome Method of Detection
Peters et al. 2000 100 Boston, MA 21% DC ICD
Vedal et al. 2004 50 Vancouver, BC 18% DC ICD
Rich et al. 2004 34 Vancouver, BC 20% DC ICD
Dockery et al. 2005a 195 Boston, MA 26% VT ICD
Dockery et al. 2005b 203 Boston, MA 25% VT ICD
Rich et al. 2005 203 Boston, MA 21% VT ICD
Ebelt et al. 2005 16 Vancouver, Canada 56% SVE Holter
Rich et al. 2006 56 St. Louis, MO NR VT ICD
Sarnat et al. 2006 30 Steubenville, OH 93% SVE & VE Holter
Berger et al. 2006 57 Efurt, Germany 0% SVT & VT Holter
Metzger et al. 2007 884 Atlanta, GA 22% VT ICD
Current study 2008 57,422 59 Exam Sites* 100% SVE & VE ECG
*

In the contiguous U.S. DC = defibrillator discharge. ECG = resting, supine, standard twelve-lead electrocardiogram. ICD = implantable cardioverter-defibrillator. NR = not reported. SVT = supraventricular tachyarrhythmia. VT = ventricular tachyarrhythmia. SVE = supraventricular ectopy. VE = ventricular ectopy.